Method of biotechnological production of bovine hemoderivative

摘要

A method of biotechnological production of a bovine hemoderivative comprising the steps of: freshly acquired animal blood matter is first fermented in several phases, the blood fermentation product obtained is dried, the dried fermentation product is separated, which is followed by ethanol extraction of the blood fermentation product in several phases, the blood fermentation product is then subjected to vacuum inspissation with subsequent stabilization after undesirable substances have been removed. The condensed extract is processed with etheric preparation during which the condensed blood fermentation product is subjected to ether precipitation, and the precipitate, thus obtained is separated from the solution of undesirable substances soluble in ether.

主权项

1. A method of biotechnological production of bovine hemoderivative, the method comprising:
a) acquiring fresh bovine blood and fermenting said acquired blood in two phases comprising the steps of: in a first fermentation phase, putting said acquired blood into containers wherein the blood mass level height is 2.5-3 cm in the containers and gradually heating the surrounding air temperature to 80° C. and the temperature of the acquired blood reaches a temperature of 55-65° C.; decreasing the surrounding air temperature to 65-75° C. to begin a second fermentation phase and when the decreased surrounding air temperature is reached, the second fermentation phase proceeds during which a constant temperature difference of 5° C. is maintained between the surrounding air and the temperature of said blood, during which phase autoenzymatic cleavage of blood takes place until the entire blood passes into a gummy consistency to yield a blood fermentation product; b) drying said obtained blood fermentation product through controlled ventilation according to a drying curve at 60-80° C. for 120-160 hours to a final humidity content of up to 10% to a dried blood fermentation product; c) disintegrating said dried blood fermentation product to particles sizes of 1-10 mm; d) extracting said resultant disintegrated dried blood fermentation product by continual extraction in four phases through the action of pure ethanol in an extractor of Soxhlet type, using a total extraction time of 150-400 hours at 70-78° C., and joining the resultant extracts of dried blood fermentation products, wherein said obtained joined extracts are subjected to stabilization through separation of undesirable blood salts, at ambient temperature for 24-120 hours to obtain a stabilized blood fermentation product; e) subsequently, the stabilized blood fermentation product is subjected to one vacuum inspissation to a resulting concentration that is approximately 20 times higher than the original concentration, f) after subsequent vacuum inspissation, the resultant stabilized condensed blood fermentation product extract is subjected to ether preparation in several phases to obtain a precipitate of a bovine hemoderivative, then dissolving said precipitate in ethanol to obtain a solution of the bovine hemoderivative; subjecting the solution to a second ether preparation to obtain a mixture of a second precipitate having a solution overlying the second precipitate which contains undesirable phospholipids soluble in ether; g) dissolving the mixture in ethanol until a true solution forms, and subjecting the true solution to vacuum inspissation at 25-40° C. until a plain ether distillate and an evaporation residue are obtained; and h) whereupon the evaporation residue containing ethanol is standardized to obtain a concentration of the bovine hemoderivative in water.